A repositioning of players in the MSR market is underway
The growing role of private investors, new capital rules and industry consolidation are among the variables propelling change in the MSR market.
Stay updated with breaking news from Mike Carnes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The growing role of private investors, new capital rules and industry consolidation are among the variables propelling change in the MSR market.
The mortgage-servicing rights (MSR) market remains robust as we turn the corner into 2024, and though it is expected to slightly underperform 2023, the market is still projected to notch healthy trading volumes in 2024 — hovering near the $1 trillion mark for the fourth year in a row, market observers forecast.
Even in this bull MSR market, there are headwinds to keep an eye on going forward: bank MSR portfolios are shrinking, IMBs are on a treadmill and there are growing concerns about future trading volumes.
Elevated buyback pressure from Fannie and Freddie is particularly acute for small, struggling lenders seeking to sell mortgage-servicing rights (MSRs).
Cereius, Inc., a biotechnology company developing therapies to treat cancer that has spread to the brain, has been acquired by San Diego-based Solve Therapeutics, Inc. (SolveTx).